Marker genes for the metabolic adaptation of Pseudomonas aeruginosa to the hypoxic cystic fibrosis lung environment

International Journal of Medical Microbiology

Volumn 304, Issue 8, 2014, Pages 1050-1061

  Eichner, Anja ^a   Günther, Nicole ^a   Arnold, Martin ^a   Schobert, Max ^a   Heesemann, Jürgen ^a   Hogardt, Michael ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Artificial sputum medium; Cystic fibrosis; Isocitrate dehydrogenase; Metabolic adaptation; Oxygen limitation; Pseudomonas aeruginosa

Indexed keywords

ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASES ICD; ISOCITRATE DEHYDROGENASES IDH; ISOENZYME; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG; GENETIC MARKER;

ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; CYSTIC FIBROSIS; GENE; GENE EXPRESSION; GROWTH CURVE; HYPOXIC CYSTIC FIBROSIS; LUNG; LUNG DISEASE; MARKER GENE; MUCUS; NONHUMAN; PSEUDOMONAS AERUGINOSA; SPUTUM; ADAPTATION; ANOXIA; COMPLICATION; GENETIC MARKER; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION;

ADAPTATION, BIOLOGICAL; ANOXIA; CYSTIC FIBROSIS; GENE EXPRESSION; GENETIC MARKERS; HUMANS; ISOCITRATE DEHYDROGENASE; METABOLIC NETWORKS AND PATHWAYS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS;

EID: 84911995699     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2014.07.014     Document Type: Article

References (57)

1. Alvarez-Ortega C., Harwood C.S. Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Mol. Microbiol. 2007, 65:153-165.
2. Arai H., Igarashi Y., Kodama T. Expression of the nir and nor genes for denitrification of Pseudomonas aeruginosa requires a novel CRP/FNR-related transcriptional regulator, DNR, in addition to ANR. FEBS Lett. 1995, 371:73-76.
3. Banerjee S., Nandyala A., Podili R., Katoch V.M., Hasnain S.E. Comparison of Mycobacterium tuberculosis isocitrate dehydrogenases (ICD-1 and ICD-2) reveals differences in coenzyme affinity, oligomeric state, pH tolerance and phylogenetic affiliation. BMC. Biochem. 2005, 6:20.
4. Barth A.L., Pitt T.L. The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J. Med Microbiol. 1996, 45:110-119.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
6. +-specific isocitrate dehydrogenase of Escherichia coli. II. Subunit structure. Biochim. Biophys. Acta 1974, 351:333-340.
7. Chen F., Xia Q., Ju L.K. Competition between oxygen and nitrate respirations in continuous culture of Pseudomonas aeruginosa performing aerobic denitrification. Biotechnol. Bioeng. 2006, 93:1069-1078.
8. Comolli J.C., Donohue T.J. Differences in two Pseudomonas aeruginosa cbb3 cytochrome oxidases. Mol. Microbiol. 2004, 51:1193-1203.
9. Döring G., Parameswaran I.G., Murphy T.F. Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease. FEMS Microbiol. Rev. 2011, 35:124-146.
10. Eikmanns B.J., Rittmann D., Sahm H. Cloning, sequence analysis, expression, and inactivation of the Corynebacterium glutamicum icd gene encoding isocitrate dehydrogenase and biochemical characterization of the enzyme. J. Bacteriol. 1995, 177:774-782.
11. Eisenreich W., Dandekar T., Heesemann J., Goebel W. Carbon metabolism of intracellular bacterial pathogens and possible links to virulence. Nat. Rev. Microbiol. 2010, 8:401-412.
12. Eschbach M., Schreiber K., Trunk K., Buer J., Jahn D., Schobert M. Long-term anaerobic survival of the opportunistic pathogen Pseudomonas aeruginosa via pyruvate fermentation. J. Bacteriol. 2004, 186:4596-4604.
13. Figurski D.H., Helinski D.R. Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc. Natl. Acad. Sci. U.S.A. 1979, 76:1648-1652.
14. Fung C., Naughton S., Turnbull L., Tingpej P., Rose B., Arthur J., Hu H., Harmer C., Harbour C., Hassett D.J., Whitchurch C.B., Manos J. Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum. J. Med. Microbiol. 2010, 59:1089-1100.
15. Hoboth C., Hoffmann R., Eichner A., Henke C., Schmoldt S., Imhof A., Heesemann J., Hogardt M. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J. Infect. Dis. 2009, 200:118-130.
16. Hogardt M., Heesemann J. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung. Curr. Top. Microbiol. Immunol. 2012, 358:91-118.
17. Hogardt M., Hoboth C., Schmoldt S., Henke C., Bader L., Heesemann J. Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis. J. Infect. Dis. 2007, 195:70-80.
18. Hogardt M., Roeder M., Schreff A.M., Eberl L., Heesemann J. Expression of Pseudomonas aeruginosa exoS is controlled by quorum sensing and RpoS. Microbiology 2004, 150:843-851.
19. Hogardt M., Schubert S., Gotzfried M., Heesemann J. Sequence variability and functional analysis of MutS of hypermutable Pseudomonas aeruginosa cystic fibrosis isolates. Int. J. Med. Microbiol. 2006, 296:313-320.
20. Ishii A., Ochiai T., Imagawa S., Fukunaga N., Sasaki S., Minowa O., Mizuno Y., Shiokawa H. Isozymes of isocitrate dehydrogenase from an obligately psychrophilic bacterium, Vibrio sp. strain ABE-1: purification, and modulation of activities by growth conditions. J. Biochem. 1987, 102:1489-1498.
21. Jackson A.A., Gross M.J., Daniels E.F., Hampton T.H., Hammond J.H., Vallet-Gely I., Dove S.L., Stanton B.A., Hogan D.A. Anr and its activation by PlcH activity in Pseudomonas aeruginosa host colonization and virulence. J. Bacteriol. 2013, 195:3093-3104.
22. Jung I.L., Kim S.K., Kim I.G. The RpoS-mediated regulation of isocitrate dehydrogenase gene expression in Escherichia coli. Curr. Microbiol. 2006, 52:21-26.
23. Kirchner S., Fothergill J.L., Wright E.A., James C.E., Mowat E., Winstanley C. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung. J. Vis. Ex. 2012, pe3857.
24. Kohanski M.A., Dwyer D.J., Hayete B., Lawrence C.A., Collins J.J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007, 130:797-810.
25. Kovach M.E., Phillips R.W., Elzer P.H., Roop R.M., Peterson K.M. pBBR1MCS: a broad- host-range cloning vector. Biotechniques 1994, 16:800-802.
26. Krieger R., Rompf A., Schobert M., Jahn D. The Pseudomonas aeruginosa hemA promoter is regulated by Anr, Dnr, NarL and integration host factor. Mol. Genet. Genomics 2002, 267:409-417.
27. Liberati N.T., Urbach J.M., Miyata S., Lee D.G., Drenkard E., Wu G., Villanueva J., Wei T., Ausubel F.M. An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:2833-2838.
28. Maki S., Yoneta M., Takada Y. Two isocitrate dehydrogenases from a psychrophilic bacterium, Colwellia psychrerythraea. Extremophiles. 2006, 10:237-249.
29. Mena A., Smith E.E., Burns J.L., Speert D.P., Moskowitz S.M., Perez J.L., Oliver A. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J. Bacteriol. 2008, 190:7910-7917.
30. Mettert E.L., Kiley P.J. Contributions of [4Fe-4S]-FNR and integration host factor to fnr transcriptional regulation. J. Bacteriol. 2007, 189:3036-3043.
31. Miller J.H. Experiments in Molecular Genetics 1972, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
32. Oliver A. Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy. Int. J. Med. Microbiol. 2010, 300:563-572.
33. Oliver A., Canton R., Campo P., Baquero F., Blazquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000, 288:1251-1254.
34. Palmer K.L., Mashburn L.M., Singh P.K., Whiteley M. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J. Bacteriol. 2005, 187:5267-5277.
35. Platt M.D., Schurr M.J., Sauer K., Vazquez G., Kukavica-Ibrulj I., Potvin E., Levesque R.C., Fedynak A., Brinkman F.S., Schurr J., Hwang S.H., Lau G.W., Limbach P.A., Rowe J.J., Lieberman M.A., Barraud N., Webb J., Kjelleberg S., Hunt D.F., Hassett D.J. Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions. J. Bacteriol. 2008, 190:2739-2758.
36. Rodriguez-Arnedo A., Camacho M., Llorca F., Bonete M.J. Complete reversal of coenzyme specificity of isocitrate dehydrogenase from Haloferax volcanii. Protein J. 2005, 24:259-266.
37. Sahara T., Takada Y., Takeuchi Y., Yamaoka N., Fukunaga N. Cloning, sequencing, and expression of a gene encoding the monomeric isocitrate dehydrogenase of the nitrogen-fixing bacterium, Azotobacter vinelandii. Biosci. Biotechnol. Biochem. 2002, 66:489-500.
38. Schuster M., Hawkins A.C., Harwood C.S., Greenberg E.P. The Pseudomonas aeruginosa RpoS regulon and its relationship to quorum sensing. Mol. Microbiol 2004, 51:973-985.
39. Sezonov G., Joseleau-Petit D., D'Ari R. Escherichia coli physiology in Luria-Bertani broth. J Bacteriol. 2007, 189:8746-8749.
40. Son M.S., Matthews W.J., Kang Y., Nguyen D.T., Hoang T.T. In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Infect. Immun. 2007, 75:5313-5324.
41. Sonnleitner E., Hagens S., Rosenau F., Wilhelm S., Habel A., Jager K.E., Blasi U. Reduced virulence of a hfq mutant of Pseudomonas aeruginosa O1. Microb. Pathog. 2003, 35:217-228.
42. Spaink H.P., Okker R.J., Wijffelman C.A., Pees E., Lugtenberg B.J. Promoters in the nodulation region of the Rhizobium leguminosarum Sym plasmid pRL1JI. Plant Mol. Biol. 1987, 9:27-39.
43. Sriramulu D.D., Lunsdorf H., Lam J.S., Romling U. Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J. Med. Microbiol. 2005, 54:667-676.
44. Suh S.J., Silo-Suh L., Woods D.E., Hassett D.J., West S.E., Ohman D.E. Effect of rpoS mutation on the stress response and expression of virulence factors in Pseudomonas aeruginosa. J. Bacteriol. 1999, 181:3890-3897.
45. Taylor R.F., Hodson M.E., Pitt T.L. Auxotrophy of Pseudomonas aeruginosa in cystic fibrosis. FEMS Microbiol. Lett. 1992, 71:243-246.
46. Thomas S.R., Ray A., Hodson M.E., Pitt T.L. Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax 2000, 55:795-797.
47. Trunk K., Benkert B., Quack N., Munch R., Scheer M., Garbe J., Jansch L., Trost M., Wehland J., Buer J., Jahn M., Schobert M., Jahn D. Anaerobic adaptation in Pseudomonas aeruginosa: definition of the Anr and Dnr regulons. Environ. Microbiol. 2010, 12:1719-1733.
48. Vijgenboom E., Busch J.E., Canters G.W. In vivo studies disprove an obligatory role of azurin in denitrification in Pseudomonas aeruginosa and show that azu expression is under control of rpoS and ANR. Microbiology 1997, 143(Pt 9):2853-2863.
49. Vinekar R., Verma C., Ghosh I. Functional relevance of dynamic properties of Dimeric NADP-dependent isocitrate dehydrogenases. BMC. Bioinformatics. 2012, 13(Suppl 17):S2.
50. Wang A., Cao Z.Y., Wang P., Liu A.M., Pan W., Wang J., Zhu G.P. Heteroexpression and characterization of a monomeric isocitrate dehydrogenase from the multicellular prokaryote Streptomyces avermitilis MA-4680. Mol. Biol. Rep. 2011, 38:3717-3724.
51. Wang Z.X., Bramer C., Steinbuchel A. Two phenotypically compensating isocitrate dehydrogenases in Ralstonia eutropha. FEMS Microbiol. Lett. 2003, 227:9-16.
52. Winteler H.V., Haas D. The homologous regulators ANR of Pseudomonas aeruginosa and FNR of Escherichia coli have overlapping but distinct specificities for anaerobically inducible promoters. Microbiology 1996, 142(Pt 3):685-693.
53. Winsor G.L., Lam D.K., Fleming L., Lo R., Whiteside M.D., Yu N.Y., Hancock R.E., Brinkman F.S. Pseudomonas genome database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res. 2011, 39(Database issue):D596-D600.
54. Worlitzsch D., Tarran R., Ulrich M., Schwab U., Cekici A., Meyer K.C., Birrer P., Bellon G., Berger J., Weiss T., Botzenhart K., Yankaskas J.R., Randell S., Boucher R.C., Döring G. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 2002, 109:317-325.
55. Wurtzel O., Yoder-Himes D.R., Han K., Dandekar A.A., Edelheit S., Greenberg E.P., Sorek R., Lory S. The single-nucleotide resolution transcriptome of Pseudomonas aeruginosa grown in body temperature. PLoS Pathog. 2012, 8:e1002945. 10.1371/journal.ppat.1002945.
56. Ye R.W., Haas D., Ka J.O., Krishnapillai V., Zimmermann A., Baird C., Tiedje J.M. Anaerobic activation of the entire denitrification pathway in Pseudomonas aeruginosa requires Anr, an analog of Fnr. J. Bacteriol. 1995, 177:3606-3609.
57. Zimmermann A., Reimmann C., Galimand M., Haas D. Anaerobic growth and cyanide synthesis of Pseudomonas aeruginosa depend on anr, a regulatory gene homologous with fnr of Escherichia coli. Mol. Microbiol. 1991, 5:1483-1490.